High frequency of teratogen prescriptions to women of reproductive age with rheumatic disease
Arthritis Rheumatol
.
2023 Aug;75(8):1495.
doi: 10.1002/art.42461.
Epub 2023 Jul 3.
Authors
Megan E B Clowse
1
,
Jing Li
2
,
Amanda G Snyderman
3
,
Gabriela Schmajuk
3
Affiliations
1
Duke University School of Medicine, Durham, NC.
2
Division of Rheumatology, University of California, San Francisco.
3
Division of Rheumatology and the Institute for Health Policy Studies, University of California and San Francisco VA Medical Center, San Francisco, CA.
PMID:
36705556
DOI:
10.1002/art.42461
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
MeSH terms
Contraception
Female
Humans
Prescriptions
Rheumatic Diseases* / drug therapy
Teratogens*
Substances
Teratogens
Grants and funding
R01 HS028024/HS/AHRQ HHS/United States